NIH-funded research R01 grant

Engineered Tiny Oil Droplets to Fight Wound Biofilm Infections

Official title: Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections

Funded at University of Massachusetts Amherst · NIH-11360181 · Data updated 2026-11-12

A patient-focused approach using specially designed polymer nanoemulsions to tackle stubborn, antibiotic-resistant wound infections caused by biofilms.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst
NIH-funded
Lab location1 site (Hadley, United States)
Project startJuly 24, 2018
Project endJune 30, 2027
Funding year2026
Award (this year)$376,707
NIH project number5R01AI134770-09
Project IDNIH-11360181 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with chronic or acute wounds at risk for or currently infected by antibiotic-resistant biofilm-forming bacteria, such as Acinetobacter baumannii.

Less likely to help

Patients without wound infections or those with non-biofilm pathogens may not benefit from this approach.

What this research studies

This project aims to create advanced wound therapies by making crosslinked nanoemulsions that carry antimicrobial oils. These tiny droplets are stabilized in a polymer network and can be embedded into hydrogel dressings for controlled release at the wound site. The work combines nanomedicine expertise with wound biology to test effectiveness against biofilm bacteria in lab and animal models, with the goal of reducing infection and supporting healing while minimizing harm to healthy tissue. If successful, this could lead to new, more effective treatments for hard-to-treat wounds in patients with resistant infections.

Why it matters

Potential benefit: If successful, patients could experience faster clearing of stubborn wound infections and better healing with dressings that slowly release potent antimicrobials at the wound site.

How similar studies have gone: Previous studies show high kill rates against biofilms in vitro, but in vivo results are more modest, making this approach a promising but cautious next step.

Where this research is happening

  • University of Massachusetts Amherst
    Hadley, United States
    Active

Researchers

  • Principal investigator: Rotello, Vincent M. — University of Massachusetts Amherst
  • Study coordinator: Rotello, Vincent M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.